Molecular pharmacology, regulation and function of mammalian melatonin receptors.
暂无分享,去创建一个
M. Dubocovich | M. Masana | M. J. Gerdin | M. Rivera-Bermúdez | Margarita L Dubocovich | Moises A Rivera-Bermudez | Matthew J Gerdin | Monica I Masana | M. Gerdin
[1] M. Dubocovich,et al. Constitutively active melatonin MT(1) receptors in male rat caudal arteries. , 2002, European journal of pharmacology.
[2] M. Dubocovich,et al. Melatonin differentially modulates the expression and function of the hMT1 and hMT2 melatonin receptors upon prolonged withdrawal. , 2003, Biochemical pharmacology.
[3] A. Wirz-Justice,et al. Functional link between distal vasodilation and sleep-onset latency? , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[4] L. Niles,et al. Melatonin receptors on human granulosa cell membranes. , 1995, The Journal of clinical endocrinology and metabolism.
[5] M. Dubocovich,et al. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. , 1996, European journal of pharmacology.
[6] A. Sirotkin,et al. Direct regulation of mammalian reproductive organs by serotonin and melatonin. , 1997, The Journal of endocrinology.
[7] J. Wess. Molecular basis of muscarinic acetylcholine receptor function. , 1993, Trends in pharmacological sciences.
[8] R. Wurtman,et al. Melatonin in human preovulatory follicular fluid. , 1987, The Journal of clinical endocrinology and metabolism.
[9] R. Reiter. The pineal and its hormones in the control of reproduction in mammals. , 1980, Endocrine reviews.
[10] S. Reppert,et al. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Strosberg,et al. Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity. , 1999, Molecular pharmacology.
[12] D. Krause,et al. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. , 1997, The American journal of physiology.
[13] R. Nonno,et al. The melatonin receptor in the human brain: cloning experiments and distribution studies. , 1996, Brain research. Molecular brain research.
[14] L. Niles,et al. Physiological regulation of melatonin receptors in rat suprachiasmatic nuclei: diurnal rhythmicity and effects of stress , 1993, Molecular and Cellular Endocrinology.
[15] C. Allen,et al. Melatonin receptors activate heteromeric G‐protein coupled Kir3 channels , 1996, Neuroreport.
[16] P. Delagrange,et al. Melatonin receptors mediate contraction of a rat cerebral artery , 1997, Neuroreport.
[17] M. Gillette,et al. Melatonin directly resets the rat suprachiasmatic circadian clock in vitro , 1991, Brain Research.
[18] Gregory M. Brown,et al. MT(1) melatonin receptor in the human retina: expression and localization. , 2002, Investigative ophthalmology & visual science.
[19] M. Dubocovich,et al. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[20] S. Ferguson,et al. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.
[21] M. Dubocovich,et al. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. , 2001, European journal of pharmacology.
[22] J. Vanecek,et al. Developmental changes and daily rhythm in melatonin-induced inhibition of 3',5'-cyclic AMP accumulation in the rat pituitary. , 1990, Endocrinology.
[23] Christopher Browning,et al. Pharmacological characterization of human recombinant melatonin mt1 and MT2 receptors , 2000, British journal of pharmacology.
[24] D. Klein,et al. Melatonin inhibition of the in vivo pituitary response to luteinizing hormone-releasing hormone in the neonatal rat. , 1980, Neuroendocrinology.
[25] J. Vanecek,et al. Mechanisms of melatonin action in the pituitary and SCN. , 1999, Advances in experimental medicine and biology.
[26] S. Reppert,et al. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses , 1994, Neuron.
[27] D. Krause,et al. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. , 1995, European journal of pharmacology.
[28] M. Rollag,et al. Pertussis toxin blocks melatonin-induced pigment aggregation inXenopus dermal melanophores , 2004, Journal of Comparative Physiology B.
[29] P. Morgan,et al. Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor. , 2001, Biochemical and biophysical research communications.
[30] M. Gillette,et al. Circadian actions of melatonin at the suprachiasmatic nucleus , 1995, Behavioural Brain Research.
[31] Terry Kenakin,et al. Efficacy at g-protein-coupled receptors , 2002, Nature Reviews Drug Discovery.
[32] A. Gubitz,et al. Chimeric and point-mutated receptors reveal that a single glycine residue in transmembrane domain 6 is critical for high affinity melatonin binding. , 2000, Endocrinology.
[33] A. Wirz-Justice,et al. Distribution of Melatonin MT1 Receptor Immunoreactivity in Human Retina , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] M. Dubocovich,et al. Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. , 2001, American journal of physiology. Cell physiology.
[35] M. Dubocovich,et al. Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Menaker,et al. Circadian Rhythms in Cultured Mammalian Retina , 1996, Science.
[37] R. Nelson,et al. Melatonin Mediates Seasonal Changes in Immune Function , 2000, Annals of the New York Academy of Sciences.
[38] L. Devi,et al. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. , 2001, Trends in pharmacological sciences.
[39] O. Nosjean,et al. Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2* , 2000, The Journal of Biological Chemistry.
[40] R. Moore. Neural control of the pineal gland , 1995, Behavioural Brain Research.
[41] P. Witt-Enderby,et al. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells. , 1996, Molecular pharmacology.
[42] R. Foster,et al. Opsins and mammalian photoentrainment , 2002, Cell and Tissue Research.
[43] S. Reppert,et al. Melatonin receptors step into the light: cloning and classification of subtypes. , 1996, Trends in pharmacological sciences.
[44] G. Brown,et al. Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: Immunocytochemical study of mt1 melatonin receptor in guinea pig retina , 2000, Visual Neuroscience.
[45] J. Laitinen,et al. Expression of melatonin receptors in arteries involved in thermoregulation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Shibata,et al. Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro , 1989, Neuroscience Letters.
[47] S. Klein,et al. In vitro melatonin treatment enhances splenocyte proliferation in prairie voles , 2000, Journal of pineal research.
[48] M. Dubocovich,et al. Melatonin receptor subtype expression in human cerebellum. , 1998, Neuroreport.
[49] R. Baler,et al. The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. , 1997, Recent progress in hormone research.
[50] C. Allen,et al. Melatonin activates an outward current and inhibits I h in rat suprachiasmatic nucleus neurons , 1995, Brain Research.
[51] R. Nelson,et al. Melatonin Receptor Subtype MT2 (Mel 1b) and Not mt1 (Mel 1a) Is Associated with Melatonin-Induced Enhancement of Cell-Mediated and Humoral Immunity , 2001, Neuroendocrinology.
[52] A. Strosberg,et al. Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway. , 1999, Biochemical pharmacology.
[53] D. Cardinali,et al. Specific binding of melatonin in bovine brain. , 1979, Endocrinology.
[54] M. Melan,et al. Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor. , 2000, Cell motility and the cytoskeleton.
[55] V. Gribkoff,et al. Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian Clock , 1997, Neuron.
[56] K. Neve,et al. Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124. , 2001, Molecular endocrinology.
[57] M. Hastings,et al. Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. , 1993, Endocrinology.
[58] M. J. Jarzynka,et al. Down-regulation of mt1 melatonin receptors in rat ovary following estrogen exposure. , 2001, Life sciences.
[59] H. Niznik,et al. Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors , 1999, Nature Neuroscience.
[60] S. Reppert,et al. Molecular analysis of mammalian circadian rhythms. , 2001, Annual review of physiology.
[61] S. Doolen,et al. Estradiol modulates vascular response to melatonin in rat caudal artery. , 1999, American journal of physiology. Heart and circulatory physiology.
[62] C. Heward,et al. Structure-activity relationships of melatonin and related indoleamines. , 1975, Life sciences.
[63] S. Reppert,et al. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. , 1997, Endocrinology.
[64] M. Dubocovich,et al. Melatonin receptors: are there multiple subtypes? , 1995, Trends in pharmacological sciences.
[65] J. Vanecek,et al. Melatonin inhibition of GnRH-induced LH release from neonatal rat gonadotroph: involvement of Ca2+ not cAMP. , 1995, The American journal of physiology.
[66] G. Brown,et al. Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin. , 2001, Endocrinology.
[67] T. Kenakin,et al. Efficacy: Molecular Mechanisms and Operational Methods of Measurement. A New Algorithm for the Prediction of Side Effects , 2000 .
[68] D. Klein,et al. Melatonin synthesis pathway: circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retina. , 1999, Reproduction, nutrition, development.
[69] M. Dubocovich,et al. Physiological exposure to melatonin supersensitizes the cyclic adenosine 3',5'-monophosphate-dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor. , 1998 .
[70] M. Dubocovich. Characterization of a retinal melatonin receptor. , 1985, The Journal of pharmacology and experimental therapeutics.
[71] F. Mseeh,et al. Identification of cysteines involved in ligand binding to the human melatonin MT(2) receptor. , 2002, European journal of pharmacology.
[72] M. Dubocovich,et al. Melatonin receptors. , 1991, Annual review of pharmacology and toxicology.
[73] M. Dubocovich,et al. MT(2) melatonin receptors are present and functional in rat caudal artery. , 2002, The Journal of pharmacology and experimental therapeutics.
[74] M. Dubocovich. Role of melatonin in retina , 1988 .
[75] M. Dubocovich,et al. Luzindole (N-0774): a novel melatonin receptor antagonist. , 1988, The Journal of pharmacology and experimental therapeutics.
[76] L. Niles,et al. Melatonin receptor mRNA expression in human granulosa cells , 1999, Molecular and Cellular Endocrinology.
[77] P. Morgan,et al. Chimeric Melatonin mt1 and Melatonin-related Receptors , 2000, The Journal of Biological Chemistry.
[78] C. P. Mccord,et al. Evidences associating pineal gland function with alterations in pigmentation , 1917 .
[79] A. Wirz-Justice,et al. Melatonin MT-1-receptor immunoreactivity in the human eye , 2002, The British journal of ophthalmology.
[80] R. Mason,et al. The electrophysiological effects of melatonin and a putative melatonin antagonist (N-acetyltryptamine) on rat suprachiasmatic neurones in vitro , 1988, Neuroscience Letters.
[81] P. Pévet,et al. MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei , 2002, Brain Research.
[82] F. Marshall,et al. RAMPs: accessory proteins for seven transmembrane domain receptors. , 1999, Trends in pharmacological sciences.
[83] A. Eison,et al. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. , 1993, Life sciences.
[84] P. Fossier,et al. Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.
[85] J. Vanecek. Cellular mechanisms of melatonin action. , 1998, Physiological reviews.
[86] M. Gillette,et al. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. , 1997, Endocrinology.
[87] M. Migaud,et al. Biology of Mammalian Photoperiodism and the Critical Role of the Pineal Gland and Melatonin , 2001, Journal of biological rhythms.
[88] P. Pévet,et al. Melatonin receptor density is regulated in rat pars tuberalis and suprachiasmatic nuclei by melatonin itself , 1993, Brain Research.
[89] A. Strosberg,et al. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. , 1999, Molecular endocrinology.
[90] S. Snyder,et al. The pineal gland and melatonin: molecular and pharmacologic regulation. , 1999, Annual review of pharmacology and toxicology.
[91] G. Brown,et al. Expression of mt1 melatonin receptor in rat retina: evidence for multiple cell targets for melatonin , 1999, Neuroscience.
[92] M. Dubocovich,et al. Melatonin mediates two distinct responses in vascular smooth muscle. , 1998, European journal of pharmacology.
[93] O. Vakkuri,et al. Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. , 1990, The Journal of clinical endocrinology and metabolism.
[94] Terrence P. Kenakin,et al. A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .
[95] I. Beresford,et al. Pharmacological characterisation of melatonin mt1 receptor-mediated stimulation of [35S]-GTPgammaS binding. , 1998, Biochemical pharmacology.
[96] M. Dubocovich,et al. Short-Term Exposure to Melatonin Differentially Affects the Functional Sensitivity and Trafficking of the hMT1 and hMT2 Melatonin Receptors , 2003, Journal of Pharmacology and Experimental Therapeutics.
[97] M. Nelson,et al. Physiological roles and properties of potassium channels in arterial smooth muscle. , 1995, The American journal of physiology.
[98] L. Tamarkin,et al. Melatonin: a coordinating signal for mammalian reproduction? , 1985, Science.
[99] D. Sugden,et al. Design of subtype selective melatonin receptor agonists and antagonists. , 1999, Reproduction, nutrition, development.
[100] M. Gillette,et al. Signaling in the suprachiasmatic nucleus: selectively responsive and integrative , 2002, Cell and Tissue Research.
[101] M. Dubocovich,et al. Melatonin Receptor Signaling: Finding the Path Through the Dark , 2001, Science's STKE.
[102] T. Voyno-Yasenetskaya,et al. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. , 2002, Cellular signalling.
[103] M. Dubocovich. Pharmacology and function of melatonin receptors , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] D. Weaver,et al. Melatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptor , 2000, Neuroreport.
[105] M. Dubocovich. Melatonin is a potent modulator of dopamine release in the retina , 1983, Nature.
[106] D. Krause,et al. Effect of melatonin in the rat tail artery: role of K+ channels and endothelial factors , 1998, British journal of pharmacology.
[107] Circadian rhythm in experimental granulomatous inflammation is modulated by melatonin , 1997, Journal of pineal research.
[108] J. Vanecek,et al. Hypothalamic melatonin receptor sites revealed by autoradiography , 1987, Brain Research.
[109] K. Yau,et al. Melanopsin-Containing Retinal Ganglion Cells: Architecture, Projections, and Intrinsic Photosensitivity , 2002, Science.
[110] Deepshikha K Passey,et al. Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure. , 2002, Biochemical pharmacology.
[111] M. Dubocovich,et al. Autoradiographic localization of 2-[125I]iodomelatonin binding sites in the brains of C3H/HeN and C57BL/6J strains of mice. , 1990, European journal of pharmacology.
[112] M. Hastings,et al. Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin , 2002, Nature Neuroscience.
[113] A. Poso,et al. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. , 1996, European journal of pharmacology.
[114] M. Dubocovich. Therapeutic potential of melatonin receptor agonists and antagonists , 1999 .
[115] G. Nisticó,et al. Melatonin as immunomodulator in immunodeficient mice. , 1992, Immunopharmacology.
[116] G. Biella,et al. Autoradiographic localization of putative melatonin receptors in the brains of two Old World primates: Cercopithecus aethiops and Papio ursinus , 1993, Neuroscience.
[117] C. M. Singer,et al. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. , 1998, Chronobiology international.
[118] V. Gribkoff,et al. Targeted Disruption of the Mouse Mel1b Melatonin Receptor , 2003, Molecular and Cellular Biology.
[119] J. Gusella,et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[120] M. Menaker,et al. Circadian photoreception in the retinally degenerate mouse (rd/rd) , 1991, Journal of Comparative Physiology A.
[121] M. Dubocovich,et al. Responsiveness to melatonin and its receptor expression in the aging circadian clock of mice. , 1997, The American journal of physiology.
[122] R. Nonno,et al. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1‐antagonists , 1999, British journal of pharmacology.
[123] C. D. Mahle,et al. Melatonin Modulates Vascular Smooth Muscle Tone , 1997, Journal of biological rhythms.
[124] M. Walker,et al. Modulation of the rat suprachiasmatic circadian clock by melatonin in vitro , 1995, Neuroreport.
[125] M. Dubocovich,et al. Responsiveness to melatonin and its receptor expression in the aging circadian clock of mice. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.
[126] P. Delagrange,et al. Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats , 1999, British journal of pharmacology.
[127] M. Dubocovich,et al. Selective MT2 melatonin receptor antagonists block melatonin‐mediated phase advances of circadian rhythms , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[128] M. Dubocovich,et al. Melatonin Receptor‐Mediated Stimulation of Phosphoinositide Breakdown in Chick Brain Slices , 1995, Journal of neurochemistry.